Revenue cycle management is usually discussed as a financial problem: denied claims, slow reimbursement, shrinking margins. What gets left out of that conversation is who actually absorbs the damage when a revenue cycle breaks down — the patient. According to a 2025 Commonwealth Fund survey, one in five privately insured, working-age adults in the U.S. had a doctor-recommended claim denied in the past year, and nearly 70% of them said it cost their household more money. This article looks at what the data actually shows about the human cost of billing errors and claim denials, and why real-time revenue cycle visibility — rather than after the-fact reporting — is the more effective fix.
| Metric | Figure |
|---|---|
| Privately insured adults who had a claim denied in the past year | 21% |
| Denial recipients whose care was delayed | 41% |
| Denial recipients whose condition worsened | 28% |
| Denial recipients who paid more out of pocket | ~70% |
| Denial recipients still paying off related medical debt | 43% |
| Americans carrying medical debt over $250 | ~20 million |
| Total U.S. medical debt outstanding | ~$220 billion |
| Providers reporting denial rates above 10% (2025, up from 30% in 2022) | 41% |
Sources: Commonwealth Fund 2025 Affordability Survey; Peterson-KFF Health System Tracker; Experian
Health State of Claims 2025 — full citations below.
The Scale of the Problem: Medical Debt and Denied Claims
The Scale of the Problem: Medical Debt and Denied Claims The financial fallout from billing problems is not a fringe issue. Per the Peterson-KFF Health System Tracker, an estimated 20 million Americans carry medical debt exceeding $250, with 14 million owing more than $1,000 and 3 million owing more than $10,000 — adding up to roughly $220 billion in total U.S. medical debt. Using a broader definition that includes debt on credit cards or owed to family, KFF polling puts the number even higher, at 41% of adults.
Denials are a major contributor. Experian Health’s State of Claims 2025 survey found that 41% of providers now report denial rates above 10%, up from 30% in 2022 — a trend moving in the wrong direction for three straight years. More than half of respondents said claim errors are increasing, and registration or intake mistakes, which happen before a patient ever sees a clinician, already rank among the top causes of denial.
How Denials Translate Into Patient Harm
The Commonwealth Fund’s 2025 affordability survey quantifies what happens after a claim is denied:
- 41% of patients said the denial delayed their care
- 28% said their health condition worsened as a result
- Nearly 70% said the denial cost their household more money
- 43% incurred medical debt they are still paying off
- 63% reported worry or anxiety tied to the denial
Fewer than half of patients who experienced a denial attempted to appeal it — many cited confusion about their appeal rights or doubt that an appeal would succeed. Among those who did appeal, only about a third saw the denial reduced or reversed.
Regulatory responses like the No Surprises Act, which since 2022 has limited unexpected out-of-network charges for emergency and certain non-emergency services, exist precisely because billing failures had become common enough — and costly enough — to require federal intervention. That context matters: the patient-facing symptoms of a broken revenue cycle are well documented and taken seriously at a policy level, not just an operational one.
Why After-the-Fact Reporting Isn’t Enough
Most healthcare organizations still manage revenue cycle performance the way they would review last month’s financials: retrospectively. A denial surfaces weeks after the claim was submitted. A coding gap is caught during an audit, months after the service was rendered. An eligibility issue is discovered only when a claim bounces back unpaid.
By the time any of that surfaces, the patient has typically already been billed — or has already delayed or skipped a follow-up visit because of what the first bill looked like. Retrospective reporting can explain what went wrong. It can’t prevent it from happening to the next patient in the queue.
What Real-Time Revenue Visibility Changes
This is the shift Aventis Health Solutions has built its revenue cycle approach around: giving practices continuous visibility into revenue performance rather than a monthly snapshot. Instead of waiting for a period end report, practices can see clean claim rate, days in A/R, denial trends by category, net collection rate, and payer-level performance as they develop — paired with front-end steps like eligibility verification before the visit and automated claims follow-up.
The practical difference is timing. A denial pattern gets flagged while it involves a handful of claims, not an entire billing cycle. A slowdown in reimbursement from a specific payer is visible while it’s still solvable, not after it has already affected cash flow. And because eligibility and documentation issues are caught earlier in the process, fewer of them ever reach the point of becoming a patient-facing bill or denial at all.
What This Looks Like in Practice
Shifting from retrospective reporting to real-time revenue visibility generally involves a few connected changes:
- Front-end verification before the visit. Confirming eligibility, coverage, and authorization requirements before a patient is seen, rather than discovering a gap after a claim is submitted.
- Continuous claims monitoring, not month-end reporting. Tracking clean claim rate, days in A/R, and denial trends as they happen so problems can be corrected within days, not discovered a billing cycle later.
- Denial pattern recognition by category and payer. Spotting a recurring issue with a specific payer or code set early enough to fix the root cause instead of appealing the same denial repeatedly.
- Automated follow-up on outstanding claims. Reducing the number of claims that stall simply because no one followed up in time.
None of this eliminates every denial or every billing error. But it substantially narrows the gap between when a problem occurs and when someone notices — which is the gap that, left alone, tends to land on the patient.
Conclusion
Revenue cycle management is frequently treated as a purely financial discipline, but the data tells a different story: billing errors and claim denials translate directly into delayed care, worsened health outcomes, and medical debt for real patients. Moving from retrospective reporting to real-time revenue visibility is not just a technology upgrade — it is a meaningful way to reduce the number of patients who ever see a bill that shouldn’t have existed in the first place. If your organization is still discovering revenue cycle problems after they’ve already reached a patient, talk to our team about what real-time visibility could look like for your practice.
Sources
- Commonwealth Fund, How Health Insurance Coverage Denials Affect Americans (2025 Affordability Survey)
- Peterson-KFF Health System Tracker, The Burden of Medical Debt in the United States
- Experian Health, State of Claims 2025
- Consumer Financial Protection Bureau, What is a surprise medical bill and the No Surprises Act
